Home > Insider Trading > Filing (0001127602-18-027528)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711404	Cooper Companies Inc	COO	Ophthalmic Goods (3851)	942657368

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1368867	G Daniel Mcbride	The Cooper Companies, Inc. 6140 Stoneridge Mall Road, Suite 590 Pleasanton CA 94588	Evp, Coo & Pres-Coopervision	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-09-13	10,310	$95.74	38,705	No	4	M	Direct
Common Stock	Disposition	2018-09-13	4,721	$263.59	33,984	No	4	S	Direct
Common Stock	Disposition	2018-09-13	2,212	$264.22	31,772	No	4	S	Direct
Common Stock	Disposition	2018-09-13	3,058	$265.70	28,714	No	4	S	Direct
Common Stock	Disposition	2018-09-13	319	$266.50	28,395	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2018-09-13	10,310	$0.00	10,310	$95.74

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2022-12-11	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,120	Indirect	401(k) Plan

Footnotes

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.00 to $263.98. The reporting person undertakes to provide to The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
The sales price represents a weighted average of sales prices ranging between $264.00 and $264.46.
The sales price represents a weighted average of sales prices ranging between $265.26 and $266.09.
The sales price represents a weighted average of sales prices ranging between $266.38 and $266.56.
12/12/12 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/12/13; 1/5 shall vest on 12/12/14; 1/5 shall vest on 12/12/15; 1/5 shall vest on 12/12/16; and 1/5 shall vest on 12/12/17.